A systematic review and meta-analysis found that metformin use in patients with diabetes and COPD reduced the risk of COPD-related hospitalizations and showed a trend toward lower all-cause mortality without increasing the risk of hyperlactatemia [ 141 ].
← all excerpts
The Emerging Role of the Cancerous Inhibitor of Protein Phosphatase 2A in Pulmonary Diseases.
1
—
—